Melioidosis Clinical Trials

Find Melioidosis Clinical Trials Near You

Decoding the Triad: the Interplay Between Environment, Pathogen, and Host in Melioidosis (DeEPH)

Status: Recruiting
Location: See all (3) locations...
Study Type: Observational
SUMMARY

This is a longitudinal, multicentre observational study conducted across three established microbiology units integrated within hospital and community health systems in Thailand, Lao PDR, and Cambodia. The hospital cohort will enroll approximately1,000 patients with positive melioidosis. Participants will be followed at six time points from admission through one year (post-discharge) to capture acute and recovery-phase outcomes, with clinical data collected on demographics, comorbidities, exposures, treatment, adherence, and outcomes. For each confirmed case, a healthy control will be recruited within two weeks and matched by age, sex, and village of residence. Controls with no symptoms or history of melioidosis will provide a single blood sample at enrolment and will be followed by telephone at 6 and 12 months. In addition to hospital-based surveillance, a high-risk community in northern Ubon Ratchathani-referred to as the Sandbox Village-will be intensively monitored to capture subclinical infections and to assess environmental factors influencing disease acquisition. This study is funded by the Wellcome Trust. The grant reference number is 323077/Z/24/Z

Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Healthy Volunteers: t
View:

• Age ≥20 years

• Positive for Burkholderia pseudomallei from any clinical samples

• Resident of the study area for at least two years, including the follow-up period

• Willing to participate and give informed consent.

• Age ≥20 years

• Currently healthy as judged by study doctor

• Resident of the study area for at least two years, including the follow-up period

• Willing to participate and give informed consent.

• Age ≥20 years

• Resident of the study area for at least two years, including the follow-up period

• Willing to participate and give informed consent.

Locations
Other Locations
Cambodia
Cambodia-Oxford Medical Research Unit (COMRU)
NOT_YET_RECRUITING
Siem Reap
Lao People's Democratic Republic
Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit (LOMWRU)
NOT_YET_RECRUITING
Vientiane
Thailand
Sunpasitthiprosong Hospital
RECRUITING
Ubon Ratchathani
Contact Information
Primary
Kamolchanok Claire Chewapreecha, PhD
claire@tropmedres.ac
662 203 6333
Time Frame
Start Date: 2026-08-19
Estimated Completion Date: 2034-12-01
Participants
Target number of participants: 2400
Treatments
Melioidosis patients
Patients confirmed to have melioidosis
Healthy controls
Healthy controls will be enrolled for each confirmed melioidosis case. A healthy control is defined as an individual with no current fever, no evidence of soft tissue infection, and no prior history of melioidosis. Controls will be recruited within approximately two weeks of case identification and will be matched to cases by age (±5 years), sex, and village of residence.
Sandbox village cohort
All residents of the Sandbox Village, a high-risk area for melioidosis, will be enrolled to monitor disease progression and to evaluate the impact of improved water sanitation.
Related Therapeutic Areas
Sponsors
Leads: University of Oxford

This content was sourced from clinicaltrials.gov